On-demand Program: Advertising, Promotion and Labeling: the US Regulated Environment (2016)

Hear leaders from industry, regulatory agencies and the legal profession share their expertise through presentations, discussions and case studies. This program examines current guidelines and expectations for healthcare product advertising, promotion and labeling in the US and how they impact the way you communicate with prospective and end users.

Learning Objectives

  • Summarize regulations, enforcement actions, guidelines and trends affecting the advertising and promotion of medical devices, drugs and biologics
  • Identify key regulatory issues surrounding complex and rapidly shifting hot topics in advertising and promotion, with specific attention on FDA’s regulation of social media
  • Discover regulatory applications through case studies

Who Should Attend

  • Early to mid-level regulatory professionals involved in advertising and promotion of healthcare products for the US market
  • Regulatory consultants
  • Compliance specialists
  • Food and drug lawyers
  • Marketing representatives
  • Medical device attorneys
  • Medical communications professionals

Learning  Levels: Intermediate

Speakers 

Dale Cooke, president, PhillyCooke Consulting

Stefanie Doebler, special counsel, Covington & Burling LLP

Bradley Merrill Thompson, JD, MBA, RAC, attorney, Epstein Becker & Green

Richard L. Cleland, assistant director, Division of Advertising Practices, Federal Trade Commission